ArticleNucleic acids research2026
Acetylation-independent mechanism for binding of ENL to intrinsically disordered regions in TAF2/6 and SNF5.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Eleven-nineteen-leukemia (ENL) is a well-established epigenetic regulator essential for transcription in development and implicated in cancer. Here, we report the molecular mechanisms and functional consequences of the ENL association with components of transcriptional and chromatin remodeling complexes, TAF2, TAF6, and SNF5, and describe ENL intramolecular contacts and autoregulation. We show that the extra-terminal domain of ENL binds in an acetylation-independent manner to the hydrophobic motifs identified in intrinsically disordered regions of TAF2, TAF6, and SNF5. Genomic analysis reveals genome-wide co-occupancy of ENL and TAF2 or SNF5 on active promoters, and proteomic and transcriptomic analyses demonstrate increased tumor-associated correlations of ENL with TAF2, TAF6, and SNF5 and their coordinated co-expression patterns in several types of cancer. Our findings shed light on the mechanistic details by which ENL associates with chromatin cofactors and is autoregulated, paving the way for the development of novel ENL targeted antitumor interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.